Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Dr Tatjana Crnogorac-Jurcevic

Back to Search
Debernardi S, Kurotova E, Ali N, Mahamood M, Chhetri I, Pereira S, Wilson P, Greenhalf B et al. ( 2024 ) . Abstract B018: UroPanc: A large prospective observational study for validation of urinary biomarker test for the earlier detection of pancreatic adenocarcinoma . Cancer Research vol. 84 , ( 17_Supplement_2 ) b018 - b018 .
Ali N, Debernardi S, Kurotova E, Tajbakhsh J, Gupta NK, Pandol SJ, Wilson P, Pereira SP et al. ( 2024 ) . Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma . Frontiers in Oncology vol. 14 ,
Schilling K, Chen H, Glabonjat RA, Debernardi S, Blyuss O, Navas-Acien A, Halliday AN, Crnogorac-Jurcevic T ( 2024 ) . Analysis of urinary potassium isotopes and association with pancreatic health: healthy, diabetic and cancerous states . Frontiers in Endocrinology vol. 15 ,
Debernardi S, Liszka L, Ntala C, Steiger K, Esposito I, Carlotti E, Baker A, McDonald S et al. ( 2024 ) . Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma . Molecular Oncology vol. 18 , ( 3 ) 677 - 690 .
Crnogorac-Jurcevic T ( 2024 ) . A brief history of urine examination - From ancient uroscopy to 21st century urinomics . Advances in Biomarker Sciences and Technology vol. 6 , 83 - 90 .
Gao Y, Crnogorac-Jurcevic T, Budnik B ( 2024 ) . World urine project . Advances in Biomarker Sciences and Technology vol. 6 ,
Langtry A, Rabadan R, Alonso L, Lawlor R, Carrato A, Hidalgo M, Iglesias M, Molero X et al. ( 2023 ) . Complement system genetic variability shapes pancreatic cancer risk . Pancreatology vol. 23 , e28 - e29 .
He J, Alhamwe BA, Sabroso S, Carrato A, Hidalgo M, Richard XM, Coma MI, Perea J et al. ( 2023 ) . The protective effect of atopic diseases against pancreatic cancer is not driven by Th2-biomarkers . Pancreatology vol. 23 , e143 - e144 .
Srivastava K, Lines KE, Jach D, Crnogorac-Jurcevic T ( 2023 ) . S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer . Oncogene vol. 42 , ( 46 ) 3422 - 3434 .
Mikolaskova I, Crnogorac-Jurcevic T, Smolkova B, Hunakova L ( 2023 ) . Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review . Biology vol. 12 , ( 2 )
Saman H, Raza A, Patil K, Uddin S, Crnogorac-Jurcevic T ( 2022 ) . Non-Invasive Biomarkers for Early Lung Cancer Detection . Cancers vol. 14 , ( 23 )
Debernardi S, Blyuss O, Rycyk D, Srivastava K, Jeon CY, Cai H, Cai Q, Shu X et al. ( 2022 ) . Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis . International Journal of Cancer vol. 152 , ( 4 ) 769 - 780 .
Pan S, Lai LA, Simeone DM, Dawson DW, Yan Y, Crnogorac-Jurcevic T, Chen R, Brentnall TA ( 2022 ) . Proteomes of Extracellular Vesicles From Pancreatic Cancer Cells and Cancer-Associated Fibroblasts . Pancreas vol. 51 , ( 7 ) 790 - 799 .
Kartal E, Schmidt TSB, Molina-Montes E, Rodríguez-Perales S, Wirbel J, Maistrenko OM, Akanni WA, Alhamwe BA et al. ( 2022 ) . A faecal microbiota signature with high specificity for pancreatic cancer . Gut vol. 71 , ( 7 ) 1359 - 1372 .
Jach D, Cheng Y, Prica F, Dumartin L, Crnogorac-Jurcevic T ( 2021 ) . From development to cancer - an ever-increasing role of AGR2 . American Journal of Cancer Research vol. 11 , ( 11 ) 5249 - 5262 .
Kumar S, Jach D, Macfarlane W, Crnogorac-Jurcevic T ( 2021 ) . A 3-Dimensional Coculture Model to Visualize and Monitor Interaction Between Pancreatic Cancer and Islet β Cells . Pancreas vol. 50 , ( 7 ) 982 - 989 .
Rosato V, Gómez-Rubio P, Molina-Montes E, Márquez M, Löhr M, O'Rorke M, Michalski CW, Molero X et al. ( 2021 ) . Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study . European Journal of Cancer Prevention vol. 30 , ( 6 ) 423 - 430 .
Y. Liu A, Crnogorac-Jurcevic T, J. Lai J, Lam H-M ( 2021 ) . Antibody Therapy Targeting Cancer-Specific Cell Surface Antigen AGR2 . Advances in Precision Medicine Oncology , IntechOpen
De Maturana EL, Alonso L, Carrato A, Iglesias M, Molero X, Hidalgo M, Perea J, Barberá V et al. ( 2021 ) . Leukocyte-DNA methylome explains a large proportion of the risk variability of pancreatic cancer . Pancreatology vol. 21 , s13 - s14 .
Goulart MR, Watt J, Siddiqui I, Lawlor RT, Imrali A, Hughes C, Saad A, ChinAleong J et al. ( 2021 ) . Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma . npj Precision Oncology vol. 5 , ( 1 )
Brezgyte G, Shah V, Jach D, Crnogorac-Jurcevic T ( 2021 ) . Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review . Cancers vol. 13 , ( 11 )
Andersen DK, Chari ST, Costello E, Crnogorac‐Jurcevic T, Hart PA, Maitra A, Pandol SJ ( 2021 ) . New‐onset Diabetes as a Harbinger of Pancreatic Cancer: is Early Diagnosis Possible? . Clinical Pancreatology for Practising Gastroenterologists and Surgeons , Wiley
López de Maturana E, Rodríguez JA, Alonso L, Lao O, Molina-Montes E, Martín-Antoniano IA, Gómez-Rubio P, Lawlor R et al. ( 2021 ) . A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer . Genome Medicine vol. 13 , ( 1 )
Debernardi S, O’Brien H, Algahmdi AS, Malats N, Stewart GD, Plješa-Ercegovac M, Costello E, Greenhalf W et al. ( 2020 ) . A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study . PLOS Medicine vol. 17 , ( 12 )
Crnogorac-Jurcevic T, Debernardi S, Jach D, Brezgyte G, Ney A, Pereira SP, Greenhalf W, Wilson P et al. ( 2020 ) . EARLY DETECTION OF PANCREATIC ADENOCARCINOMA IN ‘AT-RISK’ POPULATIONS USING A BIOMARKER PANEL IN URINE (UROPANC) . Pancreatology . vol. 20 ,
Debernardi S, Jach D, Brezgyte G, Blyuss O, Crnogorac-Jurcevic T ( 2020 ) . A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer . Pancreatology . vol. 20 ,
Srivastava K, Lines K, Jach D, Crnogorac-Jurcevic T ( 2020 ) . S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer . Pancreatology vol. 20 ,
Daulton E, Wicaksono AN, Tiele A, Kocher HM, Debernardi S, Crnogorac-Jurcevic T, Covington JA ( 2020 ) . Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine . Talanta vol. 221 ,
Blyuss O, Crnogorac-Jurcevic T ( 2020 ) . Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients” . British Journal of Cancer vol. 123 , ( 9 ) 1468 - 1468 .
Camara R, Ogbeni D, Gerstmann L, Ostovar M, Hurer E, Scott M, Mahmoud NG, Radon T et al. ( 2020 ) . Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells . European Journal of Medicinal Chemistry112621 - 112621 .
Molina-Montes E, Coscia C, Gómez-Rubio P, Fernández A, Boenink R, Rava M, Márquez M, Molero X et al. ( 2020 ) . Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses . Gut vol. 70 , ( 2 ) 319 - 329 .
Molina-Montes E, Van Hoogstraten L, Gomez-Rubio P, Löhr M, Sharp L, Molero X, Márquez M, Michalski CW et al. ( 2020 ) . Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships . Cancer Epidemiology Biomarkers & Prevention vol. 29 , ( 5 ) 1009 - 1018 .
Schilling K, Larner F, Saad A, Roberts R, Kocher HM, Blyuss O, Halliday AN, Crnogorac-Jurcevic T ( 2020 ) . Urine metallomics signature as an indicator of pancreatic cancer . Metallomics: integrated biometal science
Blyuss O, Zaikin A, Cherepanova V, Munblit D, Kiseleva EM, Prytomanova OM, Duffy SW, Crnogorac-Jurcevic T ( 2019 ) . Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients . British Journal of Cancer vol. 122 , ( 5 ) 692 - 696 .
Crnogorac-Jurcevic T, Radon T, Shah S, Weeks M, Foster J, Sosabowski J, Dumartin L ( 2019 ) . AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting . Oncotarget
Goulart MR, Watt J, Siddique I, Lawor R, Dowe T, Bhattacharya S, Crnogorac-Jurcevic T, Allavena P et al. ( 2019 ) . Abstract 4892: Pentraxin 3: A stromal derived diagnostic biomarker for pancreatic ductal adenocarcinoma . Cancer Research . vol. 79 , 4892 - 4892 .
Blyuss O, Duffy S, Crnogorac-Jurcevic T ( 2019 ) . Development of a biomarker panel risk score, PancRISK, for early detection of pancreatic cancer .
Montes EM, van Hoogstraten L, Gómez-Rubio P, Löhr J-M, Sharp L, Molero X, Márquez M, Michalski CW et al. ( 2019 ) . Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships . Pancreatology vol. 19 , s108 - s109 .
Montes EM, Molero X, Fernández A, Estudillo L, Carrato A, Rodriguez J, Ilzarbe L, Farré A et al. ( 2019 ) . Prognostic value of reliably assessed diabetes mellitus type 2 in pancreatic cancer . Pancreatology . vol. 19 , s3 - s4 .
Barry S, Carlsen E, Marques P, Stiles CE, Gadaleta E, Berney DM, Roncaroli F, Chelala C et al. ( 2019 ) . Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors . Oncogene vol. 38 , ( 27 ) 5381 - 5395 .
Alrawashdeh W, Jones R, Dumartin L, Radon TP, Cutillas PR, Feakins RM, Dmitrovic B, Demir IE et al. ( 2019 ) . Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling . Molecular Oncology vol. 13 , ( 5 ) 1075 - 1091 .
Gomez‐Rubio P, Piñero J, Molina‐Montes E, Gutiérrez‐Sacristán A, Marquez M, Rava M, Michalski CW, Farré A et al. ( 2018 ) . Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches . International Journal of Cancer vol. 144 , ( 7 ) 1540 - 1549 .
Ntala C, Debernardi S, Feakins RM, Crnogorac-Jurcevic T ( 2018 ) . Demographic, clinical, and pathological features of early onset pancreatic cancer patients . BMC Gastroenterology vol. 18 , ( 1 )
Lee M-H, Thomas JL, Liao C-L, Jurcevic S, Crnogorac-Jurcevic T, Lin H-Y ( 2018 ) . Epitope recognition of peptide-imprinted polymers for Regenerating protein 1 (REG1) . Separation and Purification Technology vol. 192 , 213 - 219 .
Molina-Montes E, Gomez-Rubio P, Márquez M, Rava M, Löhr M, Michalski CW, Molero X, Farré A et al. ( 2018 ) . Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives . International Journal of Epidemiology vol. 47 , ( 2 ) 473 - 483 .
CRNOGORAC-JURCEVIC T ( 2017 ) . Non-invasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine . Gastroenterology
Barry S, Solomou A, Vignola L, Collier D, Carlsen E, Gadaleta E, Berney DM, Chelala C et al. ( 2017 ) . A comprehensive analysis of the AIP mutation positive pituitary tumour microenvironment: role of stromal cells and the pro-inflammatory cytokine network . Endocrine Abstracts
Marzec J, Dayem Ullah AZ, Pirrò S, Gadaleta E, Crnogorac-Jurcevic T, Lemoine NR, Kocher HM, Chelala C ( 2017 ) . The Pancreatic Expression Database: 2018 update . Nucleic Acids Res vol. 46 , ( D1 ) D1107 - D1110 .
Rubio PG, Molina-Montes E, Marquez M, Rava M, Michalski CW, Farré A, Molero X, Löhr M et al. ( 2017 ) . A reduced risk of pancreatic cancer risk is observed among subjects with autoimmune diseases . Pancreatology vol. 17 , ( 3 )
Gomez-Rubio P, Rosato V, Márquez M, Bosetti C, Molina-Montes E, Rava M, Piñero J, Michalski CW et al. ( 2017 ) . A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk . Ann Oncol vol. 28 , ( 7 ) 1618 - 1624 .
Molina-Montes E, Rosato V, Gomez-Rubio P, Löhr M, Michalski CW, Molero X, Marquez M, Ilzarbe L et al. ( 2017 ) . Association between gallbladder disease and pancreatic cancer risk according to tumour characteristics . Pancreatology vol. 17 , ( 3 ) s96 - s97 .
Wang J, Dumartin L, Mafficini A, Ulug P, Sangaralingam A, Alamiry NA, Radon TP, Salvia R et al. ( 2017 ) . Splice variants as novel targets in pancreatic ductal adenocarcinoma . Scientific Reports vol. 7 , ( 1 )
Lee M-H, Thomas JL, Liao C-L, Jurcevic S, Crnogorac-Jurcevic T, Lin H-Y ( 2017 ) . Polymers imprinted with three REG1B peptides for electrochemical determination of Regenerating Protein 1B, a urinary biomarker for pancreatic ductal adenocarcinoma . Microchimica Acta vol. 184 , ( 6 ) 1773 - 1780 .
CRNOGORAC-JURCEVIC T, Dumartin L, Alrawashdeh W, Trabulo SM, Radon TP, Steiger K, Feakins RM, di Magliano MP et al. ( 2016 ) . ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation . Oncogene
Barry S, Carlsen E, Gadaleta E, Berney D, Chelala C, Crnogorac-Jurcevic T, Korbonits M ( 2016 ) . The role of the microenvironment in the invasive phenotype of familial pituitary tumours . Endocrine Abstracts
Molina-Montes E, Gómez-Rubio P, Barberà VM, Carrato A, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Farré A, Greenhalf W et al. ( 2016 ) . Familiy history of cancer and diabetes and pancreatic cancer risk . Pancreatology vol. 16 , ( 3 )
Gomez-Rubio P, Molina-Montes E, Barberà VM, Carrato A, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Farré A, Greenhalf W et al. ( 2016 ) . Oral health and pancreatic cancer risk . Pancreatology vol. 16 , ( 3 )
Crnogorac-Jurcevic T ( 2016 ) . Urine biomarkers in pancreatic cancer . Pancreatology vol. 16 , ( 3 )
Prica F, Radon T, Cheng Y, Crnogorac-Jurcevic T ( 2016 ) . The life and works of S100P - from conception to cancer . American Journal of Cancer Research vol. 6 , ( 2 ) 562 - 576 .
Cutillas PR, Crnogorac-Jurcevic T ( 2016 ) . Application of Proteomics in Cancer Biomarker Discovery: GeLC-MS/MS . Methods in Molecular Biology vol. 1381 , 201 - 209 .
Gomez-Rubio P, Zock J-P, Rava M, Marquez M, Sharp L, Hidalgo M, Carrato A, Ilzarbe L et al. ( 2015 ) . Reduced risk of pancreatic cancer associated with asthma and nasal allergies . Gut vol. 66 , ( 2 )
Alrawashdeh W, Jones R, Wijesuriya N, Crnogorac-Jurcevic T ( 2015 ) . Perineural invasion and neuropathy in pancreatic cancer: From human tissues to a cellular model . International Journal of Surgery vol. 23 ,
Debernardi S, Massat NJ, Radon TP, Sangaralingam A, Banissi A, Ennis DP, Dowe T, Chelala C et al. ( 2015 ) . Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma . American Journal of Cancer Research vol. 5 , ( 11 ) 3455 - 3466 .
Radon TP, Massat NJ, Jones R, Alrawashdeh W, Dumartin L, Ennis D, Duffy SW, Kocher HM et al. ( 2015 ) . Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma . Clinical Cancer Research vol. 21 , ( 15 ) 3512 - 3521 .
Watt J, Siddique I, Dowe T, Crnogorac-Jurcevic T, Bhattacharya S, Allavena P, Kocher HM ( 2015 ) . Abstract A56: The role of Pentraxin 3 (PTX3) in pancreatic ductal adenocarcinoma . Cancer Research . vol. 75 , a56 - a56 .
Gomez-Rubio P, Zock J-P, Sharp L, Hidalgo M, Carrato A, Ilzarbe L, Michalski C, Molero X et al. ( 2015 ) . Asthma and nasal allergies associate with reduced pancreatic cancer risk . Pancreatology vol. 15 , ( 3 ) s124 - s125 .
Gomez-Rubio P, Scarpa A, Sharp L, Hidalgo M, Carrato A, Ilzarbe L, Michalski C, Molero X et al. ( 2015 ) . Patterns of comorbidity and multimorbidity in pancreatic cancer patients . Pancreatology vol. 15 , ( 3 )
Wong P-P, Demircioglu F, Ghazaly E, Alrawashdeh W, Stratford MRL, Scudamore CL, Cereser B, Crnogorac-Jurcevic T et al. ( 2015 ) . Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread . Cancer Cell vol. 27 , ( 1 ) 123 - 137 .
Wong P-P, Demircioglu F, Ghazaly E, Alrawashdeh W, Stratford M, Scudamore C, Cereser B, Crnogorac-Jurcevic T et al. ( 2015 ) . NOVEL DUAL-ACTION COMBINATION THERAPY ENHANCES ANGIOGENESIS WHILST REDUCING TUMOR GROWTH AND SPREAD . JOURNAL OF VASCULAR RESEARCH . vol. 52 , 6 - 6 .
Haider S, Wang J, Nagano A, Desai A, Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T et al. ( 2014 ) . A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma . Genome Medicine vol. 6 , ( 12 )
Watt J, Siddique I, Dowe T, Crnogorac-Jurcevic T, Bhattacharya S, Allavena P, Kocher H ( 2014 ) . The role of pentraxin 3 in pancreatic ductal adenocarcinoma . Pancreatology vol. 14 , ( 3 )
Watt J, Siddiqui I, Radon T, Dowe T, Crnogorac-Jurcevic T, Allavena P, Kocher H ( 2014 ) . Sa1371 Pentraxin3 Is a Stromal Biomarker in Pancreatic Ductal Adenocarcinoma . Gastroenterology vol. 146 , ( 5 ) s - 276 .
Watt J, Siddique I, Dowe T, Crnogorac-Jurcevic T, Allavena P, Kocher H ( 2014 ) . Role of PTX3 in pancreatic cancer . The Lancet vol. 383 ,
Watt J, Siddiqui I, Radon T, Dowe T, Crnogorac-Jurcevic T, Allavena P, Kocher H ( 2014 ) . Pentraxin3 Is a Stromal Biomarker in Pancreatic Ductal Adenocarcinoma . GASTROENTEROLOGY . vol. 146 , S276 - S276 .
Dayem Ullah AZ, Cutts RJ, Ghetia M, Gadaleta E, Hahn SA, Crnogorac-Jurcevic T, Lemoine NR, Chelala C ( 2014 ) . The pancreatic expression database: recent extensions and updates . Nucleic Acids Res vol. 42 , ( Database issue ) D944 - D949 .
Alrawashdeh W, Jones R, Cutillas P, Wijesuriya N, Crnogorac-Jurcevic T ( 2013 ) . Proteomic analysis of perineural invasion in pancreatic adenocarcinoma reveals up-regulation of neurosecretory protein VGF in invaded nerves . Pancreatology vol. 13 , ( 2 )
Barry S, Chelala C, Lines K, Sunamura M, Wang A, Marelli-Berg FM, Brennan C, Lemoine NR et al. ( 2013 ) . S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells . Clin Exp Metastasis vol. 30 , ( 3 ) 251 - 264 .
Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, Jurcevic S, Bronner M et al. ( 2013 ) . Molecular analysis of precursor lesions in familial pancreatic cancer . PLoS One vol. 8 , ( 1 )
Lines K, Crnogorac-Jurcevic T ( 2013 ) . S100PBP (S100P binding protein) . Atlas of Genetics and Cytogenetics in Oncology and Haematology ( 1 )
Alkhamis T, Barbic J, Crnogorac-Jurcevic T, Greenlaw RE, Peakman M, Jurcevic S ( 2012 ) . Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice . Clin Exp Immunol vol. 170 , ( 2 ) 139 - 148 .
CRNOGORAC-JURCEVIC T, LINES KE ( 2012 ) . S100PBP . Atlas of Genetics and Cytogenetics in Oncology and Haematology
Naidoo K, Jones R, Dmitrovic B, Wijesuriya N, Kocher H, Hart IR, Crnogorac-Jurcevic T ( 2012 ) . Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases . J Pathol vol. 226 , ( 5 ) 756 - 763 .
Lines KE, Chelala C, Dmitrovic B, Wijesuriya N, Kocher HM, Marshall JF, Crnogorac-Jurcevic T ( 2012 ) . S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells . Am J Pathol vol. 180 , ( 4 ) 1485 - 1494 .
Alrawashdeh W, Jones R, Cutillas P, Wijesuriya N, Crnogorac-Jurcevic T ( 2012 ) . Proteomic Analysis of Perineural Invasion in Pancreatic Adenocarcinoma Reveals Up-Regulation of Neurosecretory Protein VGF in Invaded Nerves . PANCREAS vol. 41 , ( 8 ) 1346 - 1346 .
Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio-Donahue CA, Brentnall TA, Bronner MP et al. ( 2011 ) . AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D . Cancer Res vol. 71 , ( 22 ) 7091 - 7102 .
Barry S, Crnogorac-Jurcevic T ( 2011 ) . S100P (S100 calcium binding protein P) . Atlas of Genetics and Cytogenetics in Oncology and Haematology ( 6 )
Gadaleta E, Cutts RJ, Kelly GP, Crnogorac-Jurcevic T, Kocher HM, Lemoine NR, Chelala C ( 2011 ) . A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws . Nucleic Acids Res vol. 39 , ( 18 ) 7900 - 7907 .
Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PTR, Lai C-F et al. ( 2011 ) . Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth . Breast Cancer Res Treat vol. 128 , ( 2 ) 357 - 368 .
Lines KE, Audi N, Chelala C, Wijesuriya N, Kocher H, Hurst H, Crnogorac-Jurcevic T ( 2011 ) . Abstract 1537: Role of S100PBP in pancreatic adenocarcinoma . Cancer Research vol. 71 , ( 8_Supplement ) 1537 - 1537 .
Crnogorac-Jurcevic T, Alrawashdeh W ( 2011 ) . Biomarker discovery in biological fluids . Sample Preparation in Biological Mass Spectrometry , Editors: Ivanov, AR, Lazarev, A , Springer
Cutts RJ, Gadaleta E, Hahn SA, Crnogorac-Jurcevic T, Lemoine NR, Chelala C ( 2011 ) . The Pancreatic Expression database: 2011 update . Nucleic Acids Res vol. 39 , ( Database issue ) D1023 - D1028 .
Dumartin L, Whiteman HJ, Weeks ME, Timms JF, Brentnall TA, Bronner MP, Brennan C, Lemoine NR et al. ( 2010 ) . AGR2 Regulates the Invasion of Pancreatic Cancer Cells Through Cathepsins B and D . PANCREAS vol. 39 , ( 8 ) 1318 - 1319 .
Jiang G, Cao F, Ren G, Gao D, Bhakta V, Zhang Y, Cao H, Dong Z et al. ( 2010 ) . PRSS3 promotes tumour growth and metastasis of human pancreatic cancer . Gut vol. 59 , ( 11 ) 1535 - 1544 .
Schröder C, Jacob A, Tonack S, Radon TP, Sill M, Zucknick M, Rüffer S, Costello E et al. ( 2010 ) . Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies . Mol Cell Proteomics vol. 9 , ( 6 ) 1271 - 1280 .
Lines KE, Audi N, Chelala C, Kocher H, Wijesuriya N, Hurst H, Crnogorac-Jurcevic T ( 2010 ) . Abstract 5288: S100PBP is ubiquitously expressed and modulates the function of S100 calcium-binding proteins in pancreatic cancer . Cancer Research . vol. 70 , 5288 - 5288 .
Hariharan D, Weeks ME, Crnogorac-Jurcevic T ( 2010 ) . Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE) . Methods Mol Biol vol. 576 , 197 - 211 .
Chelala C, Lemoine NR, Hahn SA, Crnogorac-Jurcevic T ( 2009 ) . A web-based platform for mining pancreatic expression datasets . Pancreatology vol. 9 , ( 4 ) 340 - 343 .
Harada T, Chelala C, Crnogorac-Jurcevic T, Lemoine NR ( 2009 ) . Genome-wide analysis of pancreatic cancer using microarray-based techniques . Pancreatology vol. 9 , ( 1-2 ) 13 - 24 .
Weeks ME, Hariharan D, Petronijevic L, Radon TR, Whiteman HJ, Kocher HM, Timms JF, Lemoine NR et al. ( 2008 ) . Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma . PROTEOM CLIN APPL vol. 2 , ( 7-8 ) 1047 - 1057 .
Barry S, Crnogorac-Jurcevic T ( 2008 ) . S100P .
Hariharan D, Crnogorac-Jurcevic T ( 2008 ) . Expression profiling of chronic pancreatitis . Pancreatitis Research Advances , Nova Publishers Ltd ( New York, USA ),
Chelala C, Hahn SA, Whiteman HJ, Barry S, Hariharan D, Radon TP, Lemoine NR, Crnogorac-Jurcevic T ( 2007 ) . Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets . BMC Genomics vol. 8 ,
Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T ( 2007 ) . The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D . Cancer Res vol. 67 , ( 18 ) 8633 - 8642 .
Sheikh A, Vimalachandran D, Thompson CC, Jenkins RE, Nedjadi T, Shekouh A, Campbell F, Dodson A et al. ( 2007 ) . The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer . Proteomics vol. 11 , ( 4 ) 1929 - 1940 .
Baril P, Gangeswaran R, Mahon PC, Caulee K, Kocher HM, Harada T, Zhu M, Kalthoff H et al. ( 2007 ) . Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway . Oncogene vol. 26 , ( 14 ) 2082 - 2094 .
Neesse A, Gangeswaran R, Luettges J, Feakins R, Weeks ME, Lemoine NR, Crnogorac-Jurcevic T ( 2007 ) . Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells . Oncogene vol. 26 , ( 11 ) 1533 - 1545 .
Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A et al. ( 2007 ) . Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility . Gut vol. 56 , ( 1 ) 95 - 106 .
Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA et al. ( 2006 ) . Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism . PLoS Med vol. 3 , ( 12 )
Neesse A, Gangeswaran R, Luettges J, Feakins R, Weeks ME, Lemoine NR, Crnogorac-Jurcevic T ( 2006 ) . Sperm associated antigen 1 (spag1) is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells . PANCREAS vol. 33 , ( 4 ) 485 - 486 .
Capurso G, Lattimore S, Crnogorac-Jurcevic T, Panzuto F, Milione M, Bhakta V, Campanini N, Swift SM et al. ( 2006 ) . Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets . Endocr Relat Cancer vol. 13 , ( 2 ) 541 - 558 .
Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W et al. ( 2005 ) . Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma . Gastroenterology vol. 129 , ( 5 ) 1454 - 1463 .
Thompson C, Ashcroft F, Saraga G, Vimalachandran D, Patel S, Prime W, Campbell F, Dodson A et al. ( 2005 ) . THE ACTIN CAPPING PROTEINS, CAPG AND GELSOLIN, ARE OVEREXPRESSED IN PANCREATIC CANCER: IMPLICATIONS FOR CANCER CELL MOTILITY AND PATIENT SURVIVAL . Pancreas vol. 31 , ( 4 ) 473 - 474 .
Vimalachandran D, Greenhalf W, Thompson C, Lüttges J, Prime W, Campbell F, Dodson A, Watson R et al. ( 2005 ) . High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients . Cancer Res vol. 65 , ( 8 ) 3218 - 3225 .
Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, Sunamura M, Matsuno S, Lemoine NR ( 2005 ) . Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer . Clin Cancer Res vol. 11 , ( 8 ) 3094 - 3101 .
Missiaglia E, Donadelli M, Palmieri M, Crnogorac-Jurcevic T, Scarpa A, Lemoine NR ( 2005 ) . Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway . Oncogene vol. 24 , ( 1 ) 199 - 211 .
Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, Hansen M, Eloranta JJ, Bhakta V, Brentnall TA, Lüttges J et al. ( 2005 ) . Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer . Am J Pathol vol. 166 , ( 1 ) 81 - 92 .
Crnogorac-Jurcevic T ( 2005 ) . Expression profiling in pancreatic cancer using microarray technology . Exocrine pancreas cancer , Editors: Gress, TM, Neoptolemos, JP, Lemoine, NR, Real, FX et al. , Solvay Pharmaceuticals
Capurso G, Crnogorac-Jurcevic T, Milione M, Panzuto F, Campanini N, Dowen SE, Di Florio A, Sette C et al. ( 2005 ) . Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas . Neuroendocrinology vol. 81 , ( 5 ) 311 - 321 .
Crnogorac-Jurcevic T, Poulsom R, Lemoine NR ( 2005 ) . The molecular pathology of cancer . Introduction to the Cellular & Molecular Biology of Cancer , Editors: Knowles, M, Selby, P , Edition. 4th , Oxford University Press ( Oxford ),
Vimalachandran CD, Watson R, Thompson CC, Campbell F, Prime W, Crnogorac-Jurcevic T, Lemoine N, Neoptolemos JP et al. ( 2004 ) . S100A6 EXPRESSION IN PANCREATIC CANCER: A NOVEL PROGNOSTIC MARKER . Pancreas vol. 29 , ( 4 )
Missiaglia E, Blaveri E, Terris B, Wang Y-H, Costello E, Neoptolemos JP, Crnogorac-Jurcevic T, Lemoine NR ( 2004 ) . Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis . Int J Cancer vol. 112 , ( 1 ) 100 - 112 .
Shekouh AR, Thompson CC, Prime W, Campbell F, Hamlett J, Herrington CS, Lemoine NR, Crnogorac-Jurcevic T et al. ( 2003 ) . Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma . Proteomics vol. 3 , ( 10 ) 1988 - 2001 .
Hughes S, Crnogorac‐Jurcevic T, Sillibourne J, Bumstead N ( 2003 ) . Assignment of a homologue of murine wingless‐type MMTV integration site family member 3a (WNT3A) to chicken chromosome 2 . Animal Genetics vol. 30 , ( 5 ) 403 - 404 .
Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP et al. ( 2003 ) . Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent . J Pathol vol. 201 , ( 1 ) 63 - 74 .
Zhu G, Reynolds L, Crnogorac-Jurcevic T, Gillett CE, Dublin EA, Marshall JF, Barnes D, D'Arrigo C et al. ( 2003 ) . Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer . Oncogene vol. 22 , ( 24 ) 3742 - 3748 .
VAN TRAPPEN P ( 2003 ) . Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer . Oncogene vol. 22 , 3742 - 3748 .
LEMOINE N, Crnogorac-Jurcevic T, Costello E, Jones M, Blaveri E, Missaglia E, Neoptolemos JP, Gangeswaran R et al. ( 2003 ) . Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent . J. Pathol. vol. 201 , 63 - 74 .
Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, Baron A, Scarpa A et al. ( 2002 ) . Expression profiling of microdissected pancreatic adenocarcinomas . Oncogene vol. 21 , ( 29 ) 4587 - 4594 .
Crnogorac-Jurcevic T, Lemoine N ( 2002 ) . Gene Expression Profiles in Normal Pancreas and Pancreatic Adenocarcinoma . Clinical Science vol. 103 , ( s47 ) 47p - 47p .
Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A, Lemoine NR ( 2002 ) . Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas . Am J Pathol vol. 160 , ( 5 ) 1745 - 1754 .
Fischer C, Bouneau L, Ozouf-Costaz C, Crnogorac-Jurcevic T, Weissenbach J, Bernot A ( 2002 ) . Conservation of the T-cell receptor alpha/delta linkage in the teleost fish Tetraodon nigroviridis . GENOMICS vol. 79 , ( 2 ) 241 - 248 .
Crnogorac-Jurcevic T, Nielsen TO, Lemoine NR ( 2002 ) . RT-PCR from Laser-Capture Microdissected Samples . RT-PCR Protocols , vol. 193 , Springer Nature
Crnogorac-Jurcevic T, Nielsen TO, Lemoine NR ( 2002 ) . RT-PCR from laser-capture microdissected samples . Methods Mol Biol vol. 193 , 197 - 204 .
Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, Jones M, Tyson K et al. ( 2001 ) . Gene expression profiles of pancreatic cancer and stromal desmoplasia . Oncogene vol. 20 , ( 50 ) 7437 - 7446 .
Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA ( 2001 ) . Inherited predisposition to pancreatic cancer . Gut vol. 48 , ( 2 ) 143 - 147 .
Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR ( 2001 ) . Pancreatic cancer genetics . Pancreatology vol. 1 , ( 6 ) 571 - 575 .
Slavov D, Crnogorac-Jurčević T, Clark M, Gardiner K ( 2000 ) . Comparative analysis of the DRADA A-to-I RNA editing gene from mammals, pufferfish and zebrafish . Gene vol. 250 , ( 1-2 ) 53 - 60 .
Lemoine NR, Sirivatanauksorn V, CRNOGORAC-JURCEVIC T ( 2000 ) . Molecular profile of pancreatic cancer . Molecular Pathogenesis of Pancreatic Cancer , vol. 41 , IOS Press
Sirivatanauksorn Y, Drury R, Crnogorac‐Jurčević T, Sirivatanauksorn V, Lemoine NR ( 1999 ) . Laser‐assisted microdissection: applications in molecular pathology . The Journal of Pathology vol. 189 , ( 2 ) 150 - 154 .
Villard L, Tassone F, Crnogorac-Jurčević T, Clancy K, Gardiner K ( 1998 ) . Analysis of pufferfish homologues of the AT-rich human APP gene . Gene vol. 210 , ( 1 ) 17 - 24 .
Crnogorac-Jurcevic T, Brown JR, Lehrach H, Schalkwyk LC ( 1997 ) . Tetraodon fluviatilis,a New Puffer Fish Model for Genome Studies . Genomics vol. 41 , ( 2 ) 177 - 184 .
Back to Search